tiprankstipranks
Trending News
More News >
Hikma Pharmaceuticals PLC (HKMPY)
OTHER OTC:HKMPY
US Market

Hikma Pharmaceuticals (HKMPY) Income Statement

Compare
44 Followers

Hikma Pharmaceuticals Income Statement

Last quarter (Q2 2025), Hikma Pharmaceuticals's total revenue was $1.66B, an increase of 16.19% from the same quarter last year. In Q2, Hikma Pharmaceuticals's net income was $238.00M. See Hikma Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 3.13B$ 2.88B$ 2.52B$ 2.55B$ 2.34B
Gross Profit
$ 1.42B$ 1.41B$ 1.24B$ 1.30B$ 1.20B
Operating Expenses
$ 803.00M$ 1.04B$ 956.00M$ 719.00M$ 622.00M
Depreciation and Amortization
$ 197.00M$ 191.00M$ 190.00M$ 167.00M$ 135.00M
EBITDA
$ 727.00M$ 559.00M$ 688.00M$ 766.00M$ 747.00M
Operating Income
$ 612.00M$ 367.00M$ 282.00M$ 582.00M$ 579.00M
Other Income/Expenses
$ -158.00M$ -86.00M$ -49.00M$ -39.00M$ -21.00M
Pretax Income
$ 454.00M$ 281.00M$ 233.00M$ 543.00M$ 558.00M
Net Income
$ 359.00M$ 190.00M$ 188.00M$ 421.00M$ 431.00M
Per Share Metrics
Basic EPS
$ 3.24$ 1.70$ 1.68$ 3.64$ 3.66
Diluted EPS
$ 3.22$ 1.72$ 1.68$ 3.62$ 3.62
Weighted Average Shares Outstanding
110.67M 111.18M 111.86M 115.50M 118.00M
Weighted Average Shares Outstanding (Diluted)
111.75M 111.18M 112.50M 116.50M 119.00M
Currency in USD

Hikma Pharmaceuticals Earnings and Revenue History